Jul 2, 20267 min
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand...
education
Practice Point®: Hematology
Hosted by Practice Point Communications · education · EN
About this Podcast:
Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
32%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for Practice Point®: Hematology.
Signup to Generate a PitchQuestions about Practice Point®: Hematology
What is Practice Point®: Hematology about?
Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more.
Who hosts Practice Point®: Hematology?
Practice Point®: Hematology is hosted by Practice Point Communications. The show has published 51 episodes to date.
What has Practice Point®: Hematology covered recently?
Recent episodes include "Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse" (2 July 2026, 7 minutes), "Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse" (2 July 2026, 8 minutes), and "Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse" (2 July 2026, 14 minutes).
How often does Practice Point®: Hematology publish?
Practice Point®: Hematology publishes roughly a few times a week, with episodes averaging 23 minutes across 51 episodes.
How hard is it to get booked on Practice Point®: Hematology?
Booking probability for Practice Point®: Hematology is 32%, and the host is rated Selective on guests. Practice Point®: Hematology requires a Pod Score of 80 or higher. Practice Point®: Hematology's contact route on record: verified email.
Who should pitch Practice Point®: Hematology?
The strongest fits for Practice Point®: Hematology are Health & Wellness Services. Practice Point®: Hematology has an education audience.
About the host
Practice Point Communications hosts Practice Point®: Hematology, an education podcast with 51 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Jul 2, 20268 minManaging relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand...
Jul 2, 202614 minManaging relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand...
Jul 2, 202616 minManaging relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand...
Jul 2, 202612 minManaging relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand...
View More
Dec 17, 202530 minS0<p>CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and...
Dec 12, 202519 minS0<p>A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint health and addressing patient...
Dec 10, 202521 minS0<p>Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed to delivering cutting-edge...
Practice Point®: Hematology
Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices
Jul 7, 202552 minS0<p>In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into...
Practice Point®: Hematology
Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care
Feb 4, 202521 minS0<p>There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series...
Practice Point®: Hematology
Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
Feb 4, 20256 minS0<p>There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series...
Practice Point®: Hematology
Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia
Feb 4, 202521 minS0<p>There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series...
Practice Point®: Hematology
Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia
Feb 4, 202522 minS0<p>There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series...
Practice Point®: Hematology
Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
Jan 20, 202547 minS0<p>Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring...
Practice Point®: Hematology
Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
Jan 20, 202519 minS0<p>What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell...
Practice Point®: Hematology
Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates from ACR Convergence 2024
Jan 20, 202547 minS0<p>In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9...
Practice Point®: Hematology
Episode 35 - 2024 Highlights and Hindsight in CLL End of Year Updates
Jan 20, 202526 minS0<p>In Highlights and Hindsight in CLL, Dr. Matthew Davids will describe the most significant ongoing studies and publications in CLL from 2024 and will detail their impact on the treatment continuum. This activity will...
Practice Point®: Hematology
Episode 34 - Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024
Jan 20, 202517 minS0<p>This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and Exposition from December 7-10, 2024, in San...
Practice Point®: Hematology
Episode 33 - Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024
Jan 20, 202522 minS0<p>Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved patient care. Dr. Guy Young will discuss...
Practice Point®: Hematology
Episode 32 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 3: Primary HLH
Jan 20, 202526 minS0<p>This third podcast episode in the series explores advanced understanding of primary hemophagocytic lymphohistiocytosis (HLH), focusing on its genetic basis, diagnostic innovations, and treatment strategies. The...
Recent guests
Recent guests on Practice Point®: Hematology. Study who booked and why before you pitch.
S
Sagar Lonial
Chair and Professor, Department of Hematology and Medical Oncology, Anne and Bernard Gray Family Chair in Cancer, Chief Medical Officer at Winship Cancer Institute, Winship Cancer Institute of Emory University
J
Joseph Mikhael, MD
Professor Applied Cancer Research and Drug Discovery; Chief Medical Officer International Myeloma Foundation, Applied Cancer Research and Drug Discovery, Translational Genomics
G
Guy Young
Director of the Hemostasis and Thrombosis Program, University of Southern California Keck School of Medicine
A
Ajai Chari
University of California, San Francisco
Best industries to pitch Practice Point®: Hematology for
PitchCentric classifies Practice Point®: Hematology under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
blooducation's podcast
25~~354 listeners87% similar
Hematology Pills
19~~264 listeners86% similar
HemeTalks: Conversations in Hematology Education
23~~332 listeners86% similar
Practice Point®: Rare Diseases
23~~322 listeners86% similar
The Hematology Podcast
20~~292 listeners86% similar
Blood Podcast
36~~521 listeners86% similar
Podcasts like Practice Point®: Hematology
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ